Brain Scientific Inc. (BRSF) Tech to be Used in a Ketamine Clinical Study for Mental Health Care
Ehave announced it will utilize BRSF's tech in an upcoming ketamine clinical studyBRSF's tech will make it possible to correlate biomarkers for the identification of chronic pain, depression, PTSD, bipolar disorder, and more. The data from this clinical trial has the potential to provide longitudinal insights that can link brain analysis and psychedelics Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is on a mission…